CSBR
Price:
$4.55
Market Cap:
$61.85M
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software pla...[Read more]
Industry
Biotechnology
IPO Date
2007-02-02
Stock Exchange
NASDAQ
Ticker
CSBR
According to Champions Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 66.07M. This represents a change of -11.48% compared to the average of 74.64M of the last 4 quarters.
The mean historical Enterprise Value of Champions Oncology, Inc. over the last ten years is 72.62M. The current 66.07M Enterprise Value has changed 9.00% with respect to the historical average. Over the past ten years (40 quarters), CSBR's Enterprise Value was at its highest in in the January 2021 quarter at 149.83M. The Enterprise Value was at its lowest in in the October 2016 quarter at 13.05M.
Average
72.62M
Median
67.41M
Minimum
24.87M
Maximum
145.90M
Discovering the peaks and valleys of Champions Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 112.98%
Maximum Annual Enterprise Value = 145.90M
Minimum Annual Increase = -43.00%
Minimum Annual Enterprise Value = 24.87M
Year | Enterprise Value | Change |
---|---|---|
2024 | 70.52M | 9.68% |
2023 | 64.29M | -36.85% |
2022 | 101.81M | -30.21% |
2021 | 145.90M | 67.91% |
2020 | 86.89M | -12.89% |
2019 | 99.75M | 112.98% |
2018 | 46.83M | 88.33% |
2017 | 24.87M | -19.71% |
2016 | 30.97M | -43.00% |
2015 | 54.34M | -1.12% |
The current Enterprise Value of Champions Oncology, Inc. (CSBR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
78.87M
5-year avg
93.88M
10-year avg
72.62M
Champions Oncology, Inc.’s Enterprise Value is less than Molecular Partners AG (130.63M), greater than MediciNova, Inc. (-41974173594.00), greater than Anebulo Pharmaceuticals, Inc. (36.46M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Pardes Biosciences, Inc. (75.90M), greater than Shattuck Labs, Inc. (6.89M), less than Eliem Therapeutics, Inc. (119.64M), less than Century Therapeutics, Inc. (104.89M), greater than Aerovate Therapeutics, Inc. (46.23M), greater than Adagene Inc. (22.22M), less than Acrivon Therapeutics, Inc. Common Stock (163.47M), less than Rezolute, Inc. (276.11M), greater than AN2 Therapeutics, Inc. (6.48M), greater than HCW Biologics Inc. (34.47M),
Company | Enterprise Value | Market cap |
---|---|---|
130.63M | $216.81M | |
-41974173594.00 | $104.47M | |
36.46M | $37.86M | |
-20511738.00 | $108.71M | |
75.90M | $135.19M | |
6.89M | $47.98M | |
119.64M | $342.68M | |
104.89M | $102.89M | |
46.23M | $76.81M | |
22.22M | $97.11M | |
163.47M | $202.87M | |
276.11M | $284.50M | |
6.48M | $39.99M | |
34.47M | $29.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Champions Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Champions Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Champions Oncology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Champions Oncology, Inc. (CSBR)?
What is the 3-year average Enterprise Value for Champions Oncology, Inc. (CSBR)?
What is the 5-year average Enterprise Value for Champions Oncology, Inc. (CSBR)?
How does the current Enterprise Value for Champions Oncology, Inc. (CSBR) compare to its historical average?